Historically, treatment of TSC-associated hamartomas has focused on a combination of active and watchful waiting, palliative treatments with drug therapy, and surgical procedures to reduce tumor burden (Table 1)
Historically, treatment of TSC-associated hamartomas has focused on a combination of active and watchful waiting, palliative treatments with drug therapy, and surgical procedures to reduce tumor burden (Table 1). Table 1 Common treatment modalities for SEGA, angiomyolipoma, skin lesions, and pulmonary LAM 0.001).56 No new lesions, evidence of increased intracranial pressure, worsened hydrocephalus, or need […]
Recent Comments